QuickView for actin filament depolymerization (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
3. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
5. Fetal liver epithelial stem/progenitor cells EPCAM+ freshly isolated or cultured in vitro

1. Simulated ischaemia induces Ca2+-independent glutamatergic vesicle release through actin filament de…
2. Actin filament remodeling by actin depolymerization factor/cofilin.
3. Changes in Xenopus oocyte nucleus and cytoplasm organization after actin filaments depolymerization …
4. Direct manipulation of malaria parasites with optical tweezers reveals distinct functions of Plasmo…
5. Cytochalasin D acts as an inhibitor of the actin-cofilin interaction.

There were no clinical trials for actin filament depolymerization